Edwards Lifesciences Reports Fourth Quarter Results
Edwards Lifesciences Corporation (EW)
Last edwards lifesciences corporation earnings: 4/23 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.edwards.com
Company Research
Source: Business Wire
IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter and full-year ended Dec. 31, 2025.Highlights and OutlookQ4 sales grew 13.3% to $1.57 billion1, constant currency2 sales grew 11.6%Q4 TAVR sales grew 12.0% to $1.16 billion1; constant currency2 sales grew 10.6%Q4 TMTT sales grew more than 40% to $156 million1 from repair and replacement therapiesQ4 EPS of $0.111; adjusted2 EPS of $0.58FY 2025 sales grew 11.5%, 10.7% constant currency2Increased confidence in FY 2026 constant currency2 sales growth of 8 – 10%FY 2026 revenue outlook includes TMTT growing 35 – 45% to $740 – $780 millionIncreased confidence in FY 2026 adjusted2 EPS $2.90 – $3.05“Edwards’ strong fourth quarter and full year performance in 2025 reflect our differentiated strategy with a clear vision around three key elements: focusing solely on structural heart, solving large, urgent and very complex patient needs, and pursuing unique opportunities to innovate
Show less
Read more
Impact Snapshot
Event Time:
EW
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EW alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EW alerts
High impacting Edwards Lifesciences Corporation news events
Weekly update
A roundup of the hottest topics
EW
News
- Edwards Lifesciences to Present at Citi's 2026 Unplugged Medtech and Life Sciences Access Day [Yahoo! Finance]Yahoo! Finance
- Edwards Lifesciences to Present at Citi’s 2026 Unplugged Medtech and Life Sciences Access DayBusiness Wire
- Halper Sadeh LLC Encourages Edwards Lifesciences Corporation Shareholders to Contact the Firm to Discuss Their RightsGlobeNewswire
- Edwards Lifesciences (NYSE:EW) was given a new $89.00 price target on by analysts at Truist Financial Corporation.MarketBeat
- Edwards Lifesciences (NYSE:EW) had its price target raised by analysts at Wells Fargo & Company from $96.00 to $100.00. They now have an "overweight" rating on the stock.MarketBeat
EW
Earnings
- 2/10/26 - Miss
EW
Sec Filings
- 2/12/26 - Form 144
- 2/10/26 - Form 8-K
- 1/12/26 - Form 8-K
- EW's page on the SEC website